전당뇨병 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global prediabetes market size is expected to reach USD 838.99 Million in 2034 from USD 363.77 Million in 2025, growing at a CAGR of 9.73 during 2026-2034.The global prediabetes market is poised for significant growth, driven by the increasing prevalence of prediabetes and the rising awareness of its health implications. Prediabetes, characterized by elevated blood sugar levels that are not yet high enough to be classified as diabetes, affects millions of individuals worldwide. As healthcare providers and patients recognize the importance of early intervention to prevent the progression to type 2 diabetes, the demand for screening, diagnostic tools, and management solutions for prediabetes is expected to rise substantially, fostering innovation and investment in this critical market.

Moreover, advancements in digital health technologies and personalized medicine are anticipated to further boost the prediabetes market. The development of mobile health applications, wearable devices, and telehealth platforms enables individuals to monitor their blood sugar levels, track lifestyle changes, and receive personalized guidance from healthcare professionals. Additionally, the growing emphasis on lifestyle modification programs, including dietary changes and physical activity, is driving the demand for comprehensive management solutions that empower individuals to take control of their health. As the healthcare landscape continues to evolve, the market for prediabetes solutions is likely to witness a surge in demand for innovative products and services that cater to diverse patient needs.

In addition, the increasing focus on regulatory compliance and public health initiatives is expected to shape the future of the prediabetes market. As governments and health organizations implement programs aimed at raising awareness and promoting preventive measures, the demand for prediabetes screening and management solutions will continue to rise. Collaborative efforts between healthcare providers, technology developers, and regulatory bodies will be essential in driving these advancements, ensuring that the prediabetes market remains responsive to the evolving needs of patients and healthcare systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Treatment & Management

• Metformin
• Digital Health and Wearables
• Glucose Monitoring Devices (CGM, BGM)
• Herbal Supplements
• Others (Probiotics and Gut Health Products, etc.)

By Gender

• Male
• Female

By Age Group

• Adult
• Pediatric

By Distribution Channel

• Online
• Offline
• Specialty Pharmacies
• Drugstores
• Supermarkets
• Hypermarkets

By Weight Category

• Overweight Individuals
• Obese Individuals (Primary Target)
• Normal Weight with Metabolic Risk (Underdiagnosed Segment)

By End User

• Hospitals
• Diagnostic Laboratories
• Home Care Settings
• Specialty Clinics
• Health and Wellness Centers

COMPANIES PROFILED

• Abbott Laboratories, APHAIA PHARMA AG, Ascensia Diabetes Care, AstraZeneca PLC, Boston Therapeutics, Inc., Bristol-Myers Squibb Company, Caelus Lifesciences, Danone S.A., Dexcom, Inc., Glenmark Pharmaceuticals Ltd., Herbalife Ltd., Medtronic plc, Nestle Health Science, Novo Nordisk A/S, Pfizer Inc., Resverlogix Corp., Sandoz Group AG, Scimar Inc., Senseonics Holdings, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Valbiotis, Viatris Inc. (Mylan Pharmaceuticals)

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PREDIABETES MARKET: BY TREATMENT & MANAGEMENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Treatment & Management
• 4.2. Metformin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Digital Health and Wearables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Glucose Monitoring Devices (CGM, BGM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Herbal Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others (Probiotics and Gut Health Products, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PREDIABETES MARKET: BY GENDER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Gender
• 5.2. Male Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Female Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PREDIABETES MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Age Group
• 6.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PREDIABETES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Offline Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Specialty Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Drugstores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Supermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Hypermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PREDIABETES MARKET: BY WEIGHT CATEGORY 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Weight Category
• 8.2. Overweight Individuals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Obese Individuals (Primary Target) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Normal Weight with Metabolic Risk (Underdiagnosed Segment) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PREDIABETES MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.6. Health and Wellness Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL PREDIABETES MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Treatment & Management
  • 10.2.2 By Gender
  • 10.2.3 By Age Group
  • 10.2.4 By Distribution Channel
  • 10.2.5 By Weight Category
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Treatment & Management
  • 10.3.2 By Gender
  • 10.3.3 By Age Group
  • 10.3.4 By Distribution Channel
  • 10.3.5 By Weight Category
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Treatment & Management
  • 10.4.2 By Gender
  • 10.4.3 By Age Group
  • 10.4.4 By Distribution Channel
  • 10.4.5 By Weight Category
  • 10.4.6 By End User
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Treatment & Management
  • 10.5.2 By Gender
  • 10.5.3 By Age Group
  • 10.5.4 By Distribution Channel
  • 10.5.5 By Weight Category
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Treatment & Management
  • 10.6.2 By Gender
  • 10.6.3 By Age Group
  • 10.6.4 By Distribution Channel
  • 10.6.5 By Weight Category
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL PREDIABETES INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Abbott Laboratories
  • 12.2.2 APHAIA PHARMA AG
  • 12.2.3 Ascensia Diabetes Care
  • 12.2.4 AstraZeneca PLC
  • 12.2.5 Boston TherapeuticsInc
  • 12.2.6 Bristol-Myers Squibb Company
  • 12.2.7 Caelus Lifesciences
  • 12.2.8 Danone S.A
  • 12.2.9 DexcomInc
  • 12.2.10 Glenmark Pharmaceuticals Ltd
  • 12.2.11 Herbalife Ltd
  • 12.2.12 Medtronic Plc
  • 12.2.13 Nestle Health Science
  • 12.2.14 Novo Nordisk A/S
  • 12.2.15 Pfizer Inc
  • 12.2.16 Resverlogix Corp
  • 12.2.17 Sandoz Group AG
  • 12.2.18 Scimar Inc
  • 12.2.19 Senseonics HoldingsInc
  • 12.2.20 Sun Pharmaceutical Industries Ltd
  • 12.2.21 Teva Pharmaceutical Industries Ltd
  • 12.2.22 Valbiotis
  • 12.2.23 Viatris Inc. (Mylan Pharmaceuticals)